Company registration number 06441306 (England and Wales)
PARAGON CARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
PARAGON CARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
PARAGON CARE LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
3
-
0
799,705
Current assets
Debtors
5
228,500
105,505
Cash at bank and in hand
549
230
229,049
105,735
Creditors: amounts falling due within one year
6
-
0
(905,164)
Net current assets/(liabilities)
229,049
(799,429)
Net assets
229,049
276
Capital and reserves
Called up share capital
220
220
Profit and loss reserves
228,829
56
Total equity
229,049
276

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 26 May 2026 and are signed on its behalf by:
Mr CJ M De Verenne
Director
Company registration number 06441306 (England and Wales)
PARAGON CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 2 -
1
Accounting policies
Company information

Paragon Care Limited is a private company limited by shares incorporated in England and Wales. The registered office is Moorgate House, King Street, Newton Abbot, United Kingdom, TQ12 2LG.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

The financial statements have been prepared on a going concern basis. The company meets its working capital requirements from a bank loan and cash received from its trading subsidiary. The directors have no reason to believe that the support of the bank or the company's trading subsidiary will be removed and therefore consider that the company is a going concern.true

1.3
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

PARAGON CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 3 -

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
-
0
799,705
PARAGON CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
3
Fixed asset investments
(Continued)
- 4 -
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 1 October 2024
799,705
Disposals
(799,705)
At 30 September 2025
-
Carrying amount
At 30 September 2025
-
At 30 September 2024
799,705
4
Subsidiaries

Details of the company's subsidiaries at 30 September 2025 are as follows:

Name of undertaking
Registered office
Nature of business
Class of
% Held
shares held
Direct
Hyde Crook Nursing Home Limited
England and Wales
Nursing Home
Ordinary
100.00
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
-
0
105,505
Other debtors
228,500
-
0
228,500
105,505
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
-
0
695,164
Other creditors
-
0
210,000
-
0
905,164
PARAGON CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 5 -
7
Loans and overdrafts
2025
2024
£
£
Bank loans
-
0
695,164
Payable within one year
-
0
695,164

Loans and borrowings falling due within and after more than one year on which security has been given by the company, includes the following liabilities:

Bank borrowings of £Nil (2024 - £695,164) are secured by a fixed and floating charge over the assets of the company.

8
Related party transactions
2025
2024
Amounts due to related parties
£
£
Key management personnel
-
210,000

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due from related parties
£
£
Other related parties
-
105,505
Other information

During the year, the company received interest from its subsidiary company totalling £Nil (2024 - £52,791).

9
Directors' transactions
Loans
% Rate
Opening balance
Amounts advanced
Closing balance
£
£
£
Directors loan balance
-
-
228,500
228,500
-
228,500
228,500
2025-09-30 2024-10-01 false false false 26 May 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Ms S K De Verenne Mr C J M De Verenne Mr CJ M De Verenne 06441306 2024-10-01 2025-09-30 06441306 2025-09-30 06441306 2024-09-30 06441306 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 06441306 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 06441306 core:CurrentFinancialInstruments 2025-09-30 06441306 core:CurrentFinancialInstruments 2024-09-30 06441306 core:ShareCapital 2025-09-30 06441306 core:ShareCapital 2024-09-30 06441306 core:RetainedEarningsAccumulatedLosses 2025-09-30 06441306 core:RetainedEarningsAccumulatedLosses 2024-09-30 06441306 bus:CompanySecretaryDirector1 2024-10-01 2025-09-30 06441306 2023-10-01 2024-09-30 06441306 core:Subsidiary1 2024-10-01 2025-09-30 06441306 core:Subsidiary1 1 2024-10-01 2025-09-30 06441306 core:WithinOneYear 2025-09-30 06441306 core:WithinOneYear 2024-09-30 06441306 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 06441306 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 06441306 bus:FRS102 2024-10-01 2025-09-30 06441306 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 06441306 bus:Director1 2024-10-01 2025-09-30 06441306 bus:Director2 2024-10-01 2025-09-30 06441306 bus:CompanySecretary1 2024-10-01 2025-09-30 06441306 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP